Fatty acid supplementation in cystic fibrosis.

Elliott's works, together with the previous works of several authors reporting low 
essential fatty acid concentrations in the serum lipids of patients with 
cystic fibrosis, stimulated us to make a pilot study treating older 
CF patients with Intralipid for 1 year. We found no side 
effects in treating older CF patients with Intralipid for 1 year. 
On the other hand the objective benefit was very limited and 
today confusing, i.e., only a slight but significant improvement in the 
renal sodium excretion after an oral sodium load was found. The 
relevance of this is speculative. 